Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study

被引：0
|
作者：
Ashina, Messoud [1 ]
Mitsikostas, Dimos D. [2 ]
Amin, Faisal M. [1 ,3 ]
Kokturk, Pinar [4 ]
Sahin, Gurdal [5 ]
Schankin, Christoph J. [6 ]
Dorman, Paul J. [7 ]
Pozo-Rosich, Patricia [8 ]
Lyras, Leonidas [4 ]
Myers, Coleen [9 ]
Ahn, Andrew H. [9 ]
Tassorelli, Cristina [10 ]
机构：
[1] Univ Copenhagen, Danish Headache Ctr, Rigshop, Copenhagen, Denmark
[2] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Athens, Greece
[3] Univ Copenhagen, Dept Neurorehabilitat Traumat Brain Injury, Righosp, Copenhagen, Denmark
[4] Teva Netherlands BV, Haarlem, Netherlands
[5] Lund Univ, Dept Clin Sci Lund, Skaneuro Neurol Clin, Lund, Sweden
[6] Univ Bern, Univ Hosp Bern, Inselspital, Bern, Switzerland
[7] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle, NSW, Australia
[8] Univ Autonoma Barcelona, Vall dHebron Hosp Res Inst, Headache Unit Res Grp, Barcelona, Spain
[9] Teva Branded Pharmaceut Prod R&D Inc, Malvern, PA USA
[10] Univ Pavia, IRCCS Mondino Fdn, Pavia, Italy
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202844
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P12-12.002
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal M.
    Kokturk, Pinar
    Sahin, Gurdal
    Schankin, Christoph J.
    Dorman, Paul J.
    Pozo-Rosich, Patricia
    Lyras, Leonidas
    Myers, Coleen
    Ahn, Andrew
    Tassorelli, Cristina
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 93 - 94
  • [2] Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
    Ashina, M.
    Mitsikostas, D.
    Amin, F. M.
    Kokturk, P.
    Sahin, G.
    Schankin, C.
    Dorman, P.
    Pozo-Rosich, P.
    Lyras, L.
    Myers, C.
    Ahn, A.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [3] Effectiveness of fremanezumab for preventive treatment of migraine: the observational PEARL study
    Ashina, M.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Poole, A.
    Sahin, G.
    Schankin, C.
    Nezadal, T.
    Lyras, L.
    Ning, X.
    Krasenbaum, L.
    Tassorelli, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 192 - 193
  • [4] Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal Mohammad
    Kokturk, Pinar
    Schankin, Christoph J.
    Sahin, Gurdal
    Pozo-Rosich, Patricia
    Dorman, Paul J.
    Nezadal, Tomas
    Poole, Anne Christine
    Martins, Isabel Pavao
    Sumelahti, Marja-Liisa
    Campos, Verena Ramirez
    Ahn, Andrew H.
    Lyras, Leonidas
    Tassorelli, Cristina
    CEPHALALGIA, 2023, 43 (11)
  • [5] Past Preventive Migraine Treatment in Patients Initiating Fremanezumab in Clinical Practice: Interim Data from the PEARL Study
    Ashina, M.
    Mitsikostas, D.
    Amin, F. M.
    Kokturk, P.
    Poole, A. C.
    Sahin, G.
    Schankin, C.
    Nezadal, T.
    Pavao Martins, I.
    Pozo-Rosich, P.
    Dorman, P.
    Sumelahti, M. L.
    Lyras, L.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [6] Fremanezumab for Preventive Treatment in Migraine: The FINESSE Study
    Straube, Andreas
    Broessner, Gregor
    Gaul, Charly
    Hamann, Xenia
    Kraya, Torsten
    Schauerte, Isabel
    Neeb, Lars
    NEUROLOGY, 2022, 98 (18)
  • [7] Fremanezumab for the preventive treatment of migraine
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Yeung, Paul P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 763 - 771
  • [8] Fremanezumab for the preventive treatment of migraine in adults
    Lionetto, Luana
    Curto, Martina
    Cisale, Giusy Ylenia
    Capi, Matilde
    Cipolla, Fabiola
    Guglielmetti, Martina
    Martelletti, Paolo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 741 - 748
  • [9] Real-world effectiveness & safety of fremanezumab in migraine: 3rd interim analysis of the pan-European PEARL study
    Ashina, M.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Schankin, C.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A.
    Martins, I.
    Sumelahti, M.
    Campos, V. Ramirez
    Ning, X.
    Lyras, L.
    Tassorelli, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 149 - 150
  • [10] Real-World effectiveness and safety of fremanezumab in migraine: 3rd interim analysis of the pan-european PEARL study
    Ashina, M.
    Mitsikostas, D. D.
    Amin, F. Mohammad
    Kokturk, P.
    Schankin, C. J.
    Sahin, G.
    Pozo-Rosich, P.
    Dorman, P.
    Nezadal, T.
    Poole, A. Christine
    Martins, I. Pavao
    Sumelahti, M. L.
    Campos, V. Ramirez
    Ning, X.
    Lyras, L.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
12345